International Biosafety: A Global Imperative

An international biosafety protocol is being debated under the Congress of the Parties to the Convention on Biodiversity (COP) that emerged from the Earth Summit in Rio de Janeiro in 1992. This might seem superficially odd. What does biodiversity have to do with biosafety? Yet the convention provides a unique opportunity to try to prevent dangerous projects with recombinant DNA and related techniques-"biotechnology" as the term is popularly used. The journey of biosafety to the COP began beca

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

The journey of biosafety to the COP began because biotech promoters convinced United Nations agencies and Third World countries that root economic problems that contribute to the loss of biodiversity can be solved by investing heavily in biotechnology. Biotech would also mine "genetic gold" from tropical biodiversity and thus provide a rationale for preserving biodiversity.

Biotech promoters managed to include in Chapter 16 of Agenda 21 (the Rio agenda for action) a $20 billion-per-year Third World investment in biotech to solve their problems and thus protect biodiversity.

Conservation organizations objected on the grounds that a crash program of investment in an expensive technology with a poor track record for living up to its assurances, even in technologically advanced countries, would be an enormous gamble. Failure of many projects is likely, and this would increase Third World debt and thus actually hasten the destruction of nature, because ob- ligations to service ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Philip Regal

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo